In silico identification and in vitro validation of alpha-hederin as a potent inhibitor of Wnt/β-catenin signaling pathway in breast cancer stem cells

In silico pharmacology Pub Date : 2024-04-12 DOI:10.1007/s40203-024-00199-z

T. Saliu, Nirwani Natasha Seneviratne, Mishal Faizan, Umapriyatharshini Rajagopalan, Damith Chathuranga Perera, Achyut Adhikari, K. Senathilake, Prasanna B. Galhena, K. Tennekoon, S. Samarakoon

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

硅学鉴定和体外验证α-hederin是乳腺癌干细胞Wnt/β-catenin信号通路的强效抑制剂

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

In silico pharmacology

自引率

0.00%

发文量

期刊最新文献

Investigating the antibacterial potential of thiophene derivatives against wound infections: a combined DFT, molecular docking, and ADMET study targeting Staphylococcus aureus, Pseudomonas aeruginosa, and Escherichia coli resistant genes. Bioactive compounds from fermented Vernonia amygdalina leaf: Potent antibiotics against multidrug-resistant Escherichia coli and Salmonella typhi. In-silico study of novel dimeric flavonoid (OC251FR2) isolated from the seeds of Garcinia kola Heckel (Clusiaceae) against alpha estrogen receptor (ER-α) of breast cancer. Phytotherapeutic potential of Campomanesia xanthocarpa (Mart.) O. Berg: antitumor effects in vitro and in silico, with emphasis on SK-MEL-28 melanoma cells-a study on leaf and fruit infusions. QSAR, molecular docking, MD simulations, and ADMET screening identify potential Heliotropium indicum leads against key targets in benign prostatic hyperplasia.